Guidelines for construction of traditional Chinese medicine pharmacovigilance system in medical institutions
The group standard Guidelines for construction of traditional Chinese medicine(TCM)pharmacovigilance system in medical institutions,managed by Chinese Association of Chinese Medicine and led by the Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences and Dongfang Hospital of Beijing University of Chinese Medicine,was announced on National Group Standard Information Platform on January 16,2024,with the standard number T/CACM 1563.2-2024.According to EU pharmacovigilance regulations and the second-level guidance principles of International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use(ICH),the unique characteristics of TCM were fully considered,and the relevant systems and procedures for constructing TCM pharmacovigilance systems in medical institutions were clearly defined.This included establishing TCM pharmacovigilance information platforms,arranging staff,formulating various regulations,and monitoring adverse reactions of TCM(including TCM decoction pieces,granules,Chinese patent medicines,in-hospital preparations,and pre-marketed Chinese patent medicines).It aimed to develop a TCM pharmacovigilance system in medical institutions that was tailored to the characteristics of TCM.The system could be appropriately adjusted according to the scope of practice and actual circumstances of medical institutions at different levels.This will enhance the implementation of TCM pharmacovigilance work and safeguard medication safety.The group standard underwent multiple rounds of consultations with internal and external experts and has ultimately evolved into a guiding document applicable to medical institutions and related entities engaged in pharmacovigilance activities.
medical institutionspharmacovigilance systemtraditional Chinese medicine
NETL
NSTL
万方数据
